Stay updated on TAPUR Study: Targeted Drug Clinical Trial
Sign up to get notified when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.

Latest updates to the TAPUR Study: Targeted Drug Clinical Trial page
- Check2 days agoChange DetectedThe webpage has updated its contact information, including new phone numbers and a change in the last update date, while also revising the version number of the document.SummaryDifference8%
- Check10 days agoChange DetectedThe page now indicates that the study has increased to 160 locations and is actively recruiting participants, with specific details about several locations and contact information for the principal investigator. Additionally, the last update date has been changed to reflect more recent information.SummaryDifference2%
- Check17 days agoChange DetectedThe webpage has been updated to include a comprehensive list of new cancer drugs, including Trastuzumab, Pertuzumab, and others, while significant sections detailing the TAPUR Study's purpose and criteria have been removed.SummaryDifference19%
- Check24 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 156 to 157, and it now includes specific contact information for the Queens Cancer Center, including names and contact details for key personnel.SummaryDifference0.7%
- Check35 days agoChange DetectedThe page has been updated to include information on Lymphosarcoma and has removed references to Multiple Myeloma, along with updates to the revision history and dates.SummaryDifference0.2%
- Check88 days agoChange DetectedThe TAPUR study has updated its information, now listing 156 locations and a new contact in Mount Kisco, New York, while removing details about 160 locations previously listed in Florida.SummaryDifference11%
Stay in the know with updates to TAPUR Study: Targeted Drug Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.